Year |
Citation |
Score |
2019 |
Assia Batzir N, Kishor Bhagwat P, Larson A, Coban Akdemir Z, Bagłaj M, Bofferding L, Bosanko KB, Bouassida S, Callewaert B, Cannon A, Enchautegui Colon Y, Garnica AD, Harr MH, Heck S, Hurst AC, et al. Recurrent Arginine Substitutions in the ACTG2 Gene are the Primary Driver of Disease Burden and Severity in Visceral Myopathy. Human Mutation. PMID 31769566 DOI: 10.1002/Humu.23960 |
0.331 |
|
2015 |
Murray ME, Lowe VJ, Graff-Radford NR, Liesinger AM, Cannon A, Przybelski SA, Rawal B, Parisi JE, Petersen RC, Kantarci K, Ross OA, Duara R, Knopman DS, Jack CR, Dickson DW. Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum. Brain : a Journal of Neurology. 138: 1370-81. PMID 25805643 DOI: 10.1093/Brain/Awv050 |
0.582 |
|
2014 |
Cannon A, Bieniek KF, Lin WL, Notari S, Zou WQ, Gambetti P, Pedraza O, Graff-Radford NR, Ferman TJ, Dickson DW. Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis. Acta Neuropathologica. 128: 313-5. PMID 24928712 DOI: 10.1007/S00401-014-1309-8 |
0.71 |
|
2014 |
Murray ME, Cannon A, Graff-Radford NR, Liesinger AM, Rutherford NJ, Ross OA, Duara R, Carrasquillo MM, Rademakers R, Dickson DW. Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathologica. 128: 411-21. PMID 24899141 DOI: 10.1007/S00401-014-1302-2 |
0.569 |
|
2014 |
D'Alton S, Altshuler M, Cannon A, Dickson DW, Petrucelli L, Lewis J. Divergent phenotypes in mutant TDP-43 transgenic mice highlight potential confounds in TDP-43 transgenic modeling. Plos One. 9: e86513. PMID 24466128 DOI: 10.1371/Journal.Pone.0086513 |
0.761 |
|
2013 |
Rutherford NJ, Lewis J, Clippinger AK, Thomas MA, Adamson J, Cruz PE, Cannon A, Xu G, Golde TE, Shaw G, Borchelt DR, Giasson BI. Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions. Brain Research. 1524: 62-73. PMID 23774650 DOI: 10.1016/J.Brainres.2013.06.006 |
0.613 |
|
2013 |
Clippinger AK, D'Alton S, Lin WL, Gendron TF, Howard J, Borchelt DR, Cannon A, Carlomagno Y, Chakrabarty P, Cook C, Golde TE, Levites Y, Ranum L, Schultheis PJ, Xu G, et al. Robust cytoplasmic accumulation of phosphorylated TDP-43 in transgenic models of tauopathy. Acta Neuropathologica. 126: 39-50. PMID 23666556 DOI: 10.1007/S00401-013-1123-8 |
0.755 |
|
2013 |
Cannon A, Fujioka S, Rutherford NJ, Ferman TJ, Broderick DF, Boylan KB, Graff-Radford NR, Uitti RJ, Rademakers R, Wszolek ZK, Dickson DW. Clinicopathologic variability of the GRN A9D mutation, including amyotrophic lateral sclerosis. Neurology. 80: 1771-7. PMID 23596077 DOI: 10.1212/Wnl.0B013E3182919059 |
0.481 |
|
2012 |
Cannon A, Yang B, Knight J, Farnham IM, Zhang Y, Wuertzer CA, D'Alton S, Lin WL, Castanedes-Casey M, Rousseau L, Scott B, Jurasic M, Howard J, Yu X, Bailey R, et al. Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction. Acta Neuropathologica. 123: 807-23. PMID 22539017 DOI: 10.1007/S00401-012-0979-3 |
0.754 |
|
2012 |
Bailey R, Cannon A, Melrose H, Farrer M, Dickson D, Lewis J. P1-195: LRRK2 modulation of neuropathology in a mouse model of tauopathy Alzheimer's & Dementia. 8: P175-P175. DOI: 10.1016/J.Jalz.2012.05.473 |
0.685 |
|
2012 |
Lewis J, Cannon A, D'Alton S, Dickson DW, Petrucelli L. S5-02-02: Lessons learned from emerging mouse models of TDP-43 proteinopathy Alzheimer's & Dementia. 8: P725-P725. DOI: 10.1016/J.Jalz.2012.05.1949 |
0.714 |
|
2012 |
D'Alton S, Altshuler M, Cannon A, Dickson D, Petrucelli L, Lewis J. O4-07-06: Influence on phenotype of the postnatal developmental period in mice expressing human M337V TDP-43 Alzheimer's & Dementia. 8: P628-P629. DOI: 10.1016/J.Jalz.2012.05.1676 |
0.732 |
|
2011 |
Abisambra J, Cannon A, O'Leary J, Brady S, Espinosa A, Jinwal U, Koren J, Blair L, Lewis J, Dickey C. O4-04-08: Neuronal tau-specific stress induction of molecular chaperones: The failure of a coping mechanism Alzheimer's & Dementia. 7: S691-S691. DOI: 10.1016/J.Jalz.2011.05.1996 |
0.577 |
|
2011 |
Cannon A, Yang B, Knight J, Farnham M, Zhang Y, Wuertzer C, D'Alton S, Howard J, Lin W, Scott B, Jurasic M, Yu X, Bailey R, Dickson D, Petrucelli L, et al. P3-006: Neurons during early development are highly vulnerable to TDP-43 dysregulation Alzheimer's & Dementia. 7: S517-S517. DOI: 10.1016/J.Jalz.2011.05.1445 |
0.724 |
|
2010 |
Lewis J, Xu Y, Cannon A, Zhang Y, Lin W, Hutton M, McGowan E, Dickson DW, Petrucelli L. O1-04-04: TDP-43 mouse models: Tools toward understanding the normal and disease roles for TDP-43 Alzheimer's & Dementia. 6: S77-S77. DOI: 10.1016/J.Jalz.2010.05.228 |
0.678 |
|
2008 |
Sando SB, Melquist S, Cannon A, Hutton M, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly J. Risk-reducing effect of education in Alzheimer's disease. International Journal of Geriatric Psychiatry. 23: 1156-62. PMID 18484674 DOI: 10.1002/Gps.2043 |
0.481 |
|
2008 |
Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway. Bmc Neurology. 8: 9. PMID 18416843 DOI: 10.1186/1471-2377-8-9 |
0.501 |
|
2008 |
Wider C, Melquist S, Hauf M, Solida A, Cobb SA, Kachergus JM, Gass J, Coon KD, Baker M, Cannon A, Stephan DA, Schorderet DF, Ghika J, Burkhard PR, Kapatos G, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology. 70: 1377-83. PMID 17804835 DOI: 10.1212/01.Wnl.0000275527.35752.C5 |
0.506 |
|
2007 |
Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, ... ... Cannon A, et al. Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 754-6. PMID 17371905 DOI: 10.1136/Jnnp.2006.109553 |
0.495 |
|
2007 |
Melquist S, Craig DW, Huentelman MJ, Crook R, Pearson JV, Baker M, Zismann VL, Gass J, Adamson J, Szelinger S, Corneveaux J, Cannon A, Coon KD, Lincoln S, Adler C, et al. Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms. American Journal of Human Genetics. 80: 769-78. PMID 17357082 DOI: 10.1086/513320 |
0.56 |
|
2007 |
Mesulam M, Johnson N, Krefft TA, Gass JM, Cannon AD, Adamson JL, Bigio EH, Weintraub S, Dickson DW, Hutton ML, Graff-Radford NR. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Archives of Neurology. 64: 43-7. PMID 17210807 DOI: 10.1001/Archneur.64.1.43 |
0.496 |
|
2007 |
Dächsel JC, Ross OA, Mata IF, Kachergus J, Toft M, Cannon A, Baker M, Adamson J, Hutton M, Dickson DW, Farrer MJ. Lrrk2 G2019S substitution in frontotemporal lobar degeneration with ubiquitin-immunoreactive neuronal inclusions. Acta Neuropathologica. 113: 601-6. PMID 17151837 DOI: 10.1007/S00401-006-0178-1 |
0.613 |
|
2006 |
Mackenzie IR, Baker M, Pickering-Brown S, Hsiung GY, Lindholm C, Dwosh E, Gass J, Cannon A, Rademakers R, Hutton M, Feldman HH. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain : a Journal of Neurology. 129: 3081-90. PMID 17071926 DOI: 10.1093/Brain/Awl271 |
0.555 |
|
2006 |
Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S, Kuntz K, Petersen R, Josephs K, Pickering-Brown SM, Graff-Radford N, Uitti R, Dickson D, et al. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Human Molecular Genetics. 15: 2988-3001. PMID 16950801 DOI: 10.1093/Hmg/Ddl241 |
0.575 |
|
2006 |
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 442: 916-9. PMID 16862116 DOI: 10.1038/Nature05016 |
0.628 |
|
2006 |
Cannon A, Baker M, Boeve B, Josephs K, Knopman D, Petersen R, Parisi J, Dickison D, Adamson J, Snowden J, Neary D, Mann D, Hutton M, Pickering-Brown SM. CHMP2B mutations are not a common cause of frontotemporal lobar degeneration. Neuroscience Letters. 398: 83-4. PMID 16431024 DOI: 10.1016/J.Neulet.2005.12.056 |
0.503 |
|
2006 |
Mackenzie IR, Baker M, West G, Woulfe J, Qadi N, Gass J, Cannon A, Adamson J, Feldman H, Lindholm C, Melquist S, Pettman R, Sadovnick AD, Dwosh E, Whiteheart SW, et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain : a Journal of Neurology. 129: 853-67. PMID 16401619 DOI: 10.1093/Brain/Awh724 |
0.535 |
|
2006 |
Melquist S, Huentelman MJ, Craig DW, Baker M, Crook R, Pearson JV, Zisman VL, Gass J, Adamson J, Szelinger S, Cournevaux JJ, Cannon A, Coon KD, Dickson DW, Stephan D, et al. P3-163: Identification of a novel risk gene for progressive supranuclear palsy by a genome-wide scan of 500,288 SNPs Alzheimer's & Dementia. 2: S422-S422. DOI: 10.1016/J.Jalz.2006.05.1431 |
0.527 |
|
Show low-probability matches. |